The Clinical journal of pain

The most recent articles from: Clin J Pain November 2022

Clin J Pain · Nov 2022

Meta Analysis

Rimegepant, Ubrogepant, and Lasmiditan in the Acute Treatment of Migraine Examining the Benefit-Risk Profile Using Number Needed to Treat/Harm.

To develop and compare benefit-risk profiles for rimegepant, ubrogepant, and lasmiditan based on a network meta-analysis (NMA) of published clinical trials. ⋯ The benefit-risk profiles of lasmiditan, rimegepant, and ubrogepant may improve clinical decision-making.

explore more…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,704,841 articles already indexed!